Recent advances in the research of heterocyclic compounds as antitubercular agents.

about

Drug-resistant tuberculous meningitis.Design, Synthesis and Antimycobacterial Activity of Novel Imidazo[1,2-a]pyridine Amide-Cinnamamide Hybrids.Tetrazole regioisomers in the development of nitro group-containing antitubercular agents

P2860

Q38113260-A5C83580-E185-43B7-A95A-E37D8474423B Q50205820-AB9A63E0-4510-4A86-A4CB-C11EAE857817 Q58260404-E0114ECD-C880-45F1-9493-6C65E2EDAE42

P2860

Recent advances in the research of heterocyclic compounds as antitubercular agents.

Item

http://www.wikidata.org/entity/Q38050102

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Recent advances in the research of heterocyclic compounds as antitubercular agents.

@en

type

Item

label

Recent advances in the research of heterocyclic compounds as antitubercular agents.

@en

prefLabel

Recent advances in the research of heterocyclic compounds as antitubercular agents.

@en

P1476

Recent advances in the research of heterocyclic compounds as antitubercular agents.

@en

P2093

Mi Yan

http://www.w3.org/2001/XMLSchema#string

Shutao Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars

Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of mycobacterium tuberculosis.

Natural products, small molecules, and genetics in tuberculosis drug development.

Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine.

New small-molecule synthetic antimycobacterials.

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections.

The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824

P304

2063-2075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201200339

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23042656

http://www.w3.org/2001/XMLSchema#string

Recent advances in the research of heterocyclic compounds as antitubercular agents.

about

P2860

P2860

Recent advances in the research of heterocyclic compounds as antitubercular agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698